bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-04 11:32 |
Décembre 2022 - Déclaration sur le nombre d'actions composant le capital social…
|
French | PDF • 106.0 KB | ||
| 2022-12-20 18:00 |
bioMérieux announces CE-marking of VIDAS® KUBE™, the next generation system in …
|
English | PDF • 400.3 KB | ||
| 2022-12-20 18:00 |
bioMérieux annonce le marquage CE de VIDAS® KUBE™, le système d'immunoessais no…
|
French | PDF • 403.8 KB | ||
| 2022-12-15 07:08 |
bioMérieux – Increased outlook for full-year 2022 and 2023 guidance preview
|
English | PDF • 177.4 KB | ||
| 2022-12-15 07:08 |
bioMérieux – Relèvement des perspectives 2022 et version préliminaire des persp…
|
French | PDF • 171.0 KB | ||
| 2022-12-05 14:30 |
Novembre 2022 - Déclaration sur le nombre d'actions composant le capital social…
|
French | PDF • 105.3 KB | ||
| 2022-11-07 08:38 |
Octobre 2022 - Déclaration sur le nombre d'actions composant le capital social …
|
French | PDF • 105.9 KB | ||
| 2022-10-26 07:01 |
bioMérieux – Third-Quarter 2022 Business Review
|
English | PDF • 214.6 KB | ||
| 2022-10-26 07:01 |
bioMérieux – Information financière du 3ème trimestre 2022
|
French | PDF • 238.6 KB | ||
| 2022-10-04 15:07 |
Septembre 2022 - Déclaration relative au nombre d'actions composant le capital …
|
French | PDF • 105.9 KB | ||
| 2022-09-26 07:01 |
New survey shows low adherence to guidelines in sepsis care puts patients at ri…
|
English | PDF • 332.6 KB | ||
| 2022-09-26 07:01 |
Sepsis : une adhérence insuffisante aux recommandations de prise en charge fait…
|
French | PDF • 0 bytes | ||
| 2022-09-02 16:43 |
Août 2022 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | PDF • 105.9 KB | ||
| 2022-09-02 08:40 |
Notice of publication of the 2022 half-year financial report
|
English | PDF • 50.4 KB | ||
| 2022-09-02 08:34 |
Avis de mise à disposition du Rapport Financier Semestriel 2022
|
French | PDF • 98.5 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
